Uncategorized

Vertex’s biggest overhang: a rival 50 times smaller

Published

on

Despite another strong earnings report, analysts warned that upcoming cystic fibrosis data from Sionna Therapeutics “looms large” over Vertex.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version